BTHS was subsequently proven by identification of a missense mutation in TAZ (exon 2, c.207C > G, p.His69Gln), which has been previously reported as causing BTHS and is a highly conserved residue, and by confirmation of an abnormal MLCL/CL ratio. The gene discussed is TAFAZZIN; the disease is Barth syndrome.